HomeBCYC • NASDAQ
add
Bicycle Therapeutics PLC
Previous close
$7.52
Day range
$7.30 - $7.65
Year range
$6.03 - $21.11
Market cap
515.40M USD
Avg Volume
356.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 11.73M | 338.49% |
Operating expense | 20.67M | -0.96% |
Net income | -59.10M | -16.33% |
Net profit margin | -503.66 | 73.47% |
Earnings per share | -0.85 | -17.50% |
EBITDA | -63.80M | -3.44% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 648.32M | -27.22% |
Total assets | 763.95M | -23.36% |
Total liabilities | 145.48M | -12.21% |
Total equity | 618.48M | — |
Shares outstanding | 69.37M | — |
Price to book | 0.84 | — |
Return on assets | -20.53% | — |
Return on capital | -25.21% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -59.10M | -16.33% |
Cash from operations | -71.17M | -78.68% |
Cash from investing | -674.00K | -54.94% |
Cash from financing | -30.00K | 99.91% |
Net change in cash | -73.13M | -3.72% |
Free cash flow | -46.27M | -61.31% |
About
CEO
Founded
2009
Website
Employees
305
